2010•Journal of Molecular Diagnostics and TherapyRequires access

Screening specific serum biomarkers of 2616 pregnant women during the second trimester

Huiling He

Open publisher page 0 citations

Abstract

Objective Toevaluatetheefficiencyof screening specific biomarkers inthesecond-trimester pregnant women.Methods Serum levels ofAFP、β-HCG and uE3 were measured by CLIAor ELISAin 2616 pregnant women during 14~24 weeks, and the risk rate was analyzed with the T21﹡SOFTw program, the high-risk pregnant women were proposed to take fetal amniotic fluid or high resolution ultrasound examination.Results The high-risk rates for Down's syndrome, 18-trisomy syndrome and neural tube defects were 5.73%, 0.34%, 1.11% respectively;there were one Down's syndrome and two neural tube defects, three other chromosomal abnormalities by prenatal diagnosis.Conclusion Screening analysis of second-trimester pregnancy serum is a major to prevent chromosomal disease and neural tube defects;the precise gestational age is the most important factor in the screening software.

About this research paper

What this paper is about

Objective Toevaluatetheefficiencyof screening specific biomarkers inthesecond-trimester pregnant women.Methods Serum levels ofAFP、β-HCG and uE3 were measured by CLIAor ELISAin 2616 pregnant women during 14~24 weeks, and the risk rate was analyzed with the T21﹡SOFTw program, the high-risk pregnant women were proposed to take fetal amniotic fluid or high resolution ultrasound examination.Results The high-risk rates for Down's syndrome, 18-trisomy syndrome and neural tube defects were 5.73%, 0.34%, 1.11% respectively;there were one Down's syndrome and two neural tube defects, three other chromosomal abnormalities by prenatal diagnosis.Conclusion Screening analysis of second-trimester pregnancy serum is a major to prevent chromosomal disease and neural tube defects;the precise gestational age is the most important factor in the screening software.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective Toevaluatetheefficiencyof screening specific biomarkers inthesecond-trimester pregnant women.Methods Serum levels ofAFP、β-HCG and uE3 were measured by CLIAor ELISAin 2616 pregnant women during 14~24 weeks, and the risk rate was analyzed with the T21﹡SOFTw program, the high-risk pregnant women were proposed to take fetal amniotic fluid or high resolution ultrasound examination.Results The high-risk rates for Down's syndrome, 18-trisomy syndrome and neural tube defects were 5.73%, 0.34%, 1.11% respectively;there were one Down's syndrome and two neural tube defects, three other chromosomal abnormalities by prenatal diagnosis.Conclusion Screening analysis of second-trimester pregnancy serum is a major to prevent chromosomal disease and neural tube defects;the precise gestational age is the most important factor in the screening software.

Key concepts: Trisomy, Medicine, Amniotic fluid, Obstetrics, Neural tube defect, Neural tube, Down syndrome, Second trimester

Related papers

Back to paper searchBrowse research topicsOriginal source
Screening specific serum biomarkers of 2616 pregnant women during the second trimester — Research Paper | ScholarLens